BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26758664)

  • 1. Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients.
    Savoia P; Ranghino A; Fava P
    Curr Drug Targets; 2017; 18(4):436-446. PubMed ID: 26758664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous viral infections in organ transplant patients.
    Piaserico S; Sandini E; Peserico A; Alaibac M
    G Ital Dermatol Venereol; 2014 Aug; 149(4):409-15. PubMed ID: 25068228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous infections from viral sources in solid organ transplant recipients.
    Ilyas M; Maganty N; Sharma A
    J Clin Virol; 2017 Dec; 97():33-37. PubMed ID: 29096391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonneoplastic mucocutaneous lesions in organ transplant recipients.
    Ponticelli C; Bencini PL
    Transpl Int; 2011 Nov; 24(11):1041-50. PubMed ID: 21806688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
    Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
    Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign Cutaneous Disease Among Polish Renal Transplant Recipients.
    Imko-Walczuk B; Okuniewska A; Prędota-Głowacka A; Jaśkiewicz J; Placek W; Włodarczyk Z; Dębska-Ślizień A; Rutkowski B
    Transplant Proc; 2016 Jun; 48(5):1660-6. PubMed ID: 27496467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Cutaneous Diseases in Renal Transplant Recipients.
    Savoia P; Cavaliere G; Zavattaro E; Veronese F; Fava P
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressant-induced cutaneous drug reactions in solid organ transplant recipients.
    Miotto IZ; Souza BCE; Tyring SK; de Oliveira WRP
    Transpl Immunol; 2021 Feb; 64():101355. PubMed ID: 33264680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous complications following liver transplantation: epidemiologic and clinical study in 86 patients].
    Salard D; Parriaux N; Derancourt C; Aubin F; Bresson-Hadni S; Miguet JP; Laurent R
    Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1134-8. PubMed ID: 12442126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin Cancer Risk Awareness and Sun-Protective Behavior Among Solid-Organ Transplant Recipients.
    Tunçer Vural A; Karataş Toğral A; Kırnap M; Güleç AT; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):203-207. PubMed ID: 29528028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of skin disease following renal transplantation on quality of life.
    Moloney FJ; Keane S; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2005 Sep; 153(3):574-8. PubMed ID: 16120145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous manifestations of immunosuppression in organ transplant recipients.
    Abel EA
    J Am Acad Dermatol; 1989 Aug; 21(2 Pt 1):167-79. PubMed ID: 2671063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin cancers and other cutaneous diseases in renal transplant recipients: a single Italian center observational study.
    Savoia P; Stroppiana E; Cavaliere G; Osella-Abate S; Mezza E; Segoloni GP; Bernengo MG
    Eur J Dermatol; 2011; 21(2):242-7. PubMed ID: 21382788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infections in solid organ transplant recipients].
    Cuellar-Rodríguez J; Sierra-Madero JG
    Rev Invest Clin; 2005; 57(2):368-80. PubMed ID: 16524080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation, immunosuppression and the skin: an update.
    Moloney FJ; de Freitas D; Conlon PJ; Murphy GM
    Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):1-8. PubMed ID: 15634217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
    Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic deep cutaneous mycoses in solid organ transplant recipients.
    Tessari G; Cagalli A; Girolomoni G
    G Ital Dermatol Venereol; 2014 Aug; 149(4):417-22. PubMed ID: 25068229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ transplantation and skin--principles and concepts.
    Hofbauer GF; Freiberger SN; Iotzova-Weiss G; Shafaeddin B; Dziunycz PJ
    Curr Probl Dermatol; 2012; 43():1-8. PubMed ID: 22377915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin cancer risk associated with immunosuppressive therapy in organ transplant recipients: epidemiology and proposed mechanisms.
    Kuijken I; Bavinck JN
    BioDrugs; 2000 Nov; 14(5):319-29. PubMed ID: 18034576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus-based immunosuppression for treatment of cutaneous warts in kidney transplant recipients.
    Shahidi S; Moeinzadeh F; Mohammadi M; Gholamrezaei A
    Iran J Kidney Dis; 2011 Sep; 5(5):351-3. PubMed ID: 21876315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.